Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you manage pleomorphic adenoma of minor salivary glands involving hypopharynx/larynx with positive surgical margin?
Would you offer adjuvant radiation? Dose/volume in postop setting?
Answer from: Radiation Oncologist at Academic Institution
Postop RT with carcinoma doses.
Sign in or Register to read more
16851
Related Questions
In oral cavity cancers, how does WPOI (worse pattern of invasion) influence your decision to offer adjuvant therapy?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
How would you treat a stage IIA NS HD patient with bulky disease who refuses chemotherapy?
Are there any special treatment considerations when treating a patient with laryngeal cancer with significant Reinke's edema of the vocal folds?
Would you consider palliative RT in the setting of tumor causing osteonecrosis in an elderly patient?
In what cases of T3N0 glottic SCC, would you omit chemotherapy and offer radiation alone?
Does the extent of ENE affect your recommendation for concurrent chemotherapy in HPV+ OPSCC patients planned for adjuvant RT?
How would you manage worsening severe macroglossia affecting function in a patient after definitive chemoradiation in the subacute setting for p16+ SCC of the base of tongue?
When would you offer definitive or adjuvant RT for solitary fibrous tumor or hemangiopericytoma in the head and neck?
How should you approach treating curable laryngeal cancer with chemo-RT in a patient who had a myocardial infarction during treatment and requires CABG, given the cardiotoxicity of cisplatin and 5FU/carboplatin?